PetIQ Inc (NASDAQ:PETQ) CFO John Newland sold 42,778 shares of PetIQ stock in a transaction dated Tuesday, September 4th. The shares were sold at an average price of $40.15, for a total value of $1,717,536.70. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website.

John Newland also recently made the following trade(s):

  • On Friday, August 24th, John Newland sold 27,222 shares of PetIQ stock. The shares were sold at an average price of $40.00, for a total value of $1,088,880.00.
  • On Monday, August 13th, John Newland sold 5,500 shares of PetIQ stock. The shares were sold at an average price of $26.78, for a total value of $147,290.00.
  • On Tuesday, July 17th, John Newland sold 5,500 shares of PetIQ stock. The shares were sold at an average price of $26.03, for a total value of $143,165.00.
  • On Wednesday, June 27th, John Newland sold 11,000 shares of PetIQ stock. The shares were sold at an average price of $25.25, for a total value of $277,750.00.
  • On Thursday, June 21st, John Newland sold 5,500 shares of PetIQ stock. The shares were sold at an average price of $24.53, for a total value of $134,915.00.

Shares of NASDAQ PETQ traded down $0.58 during midday trading on Friday, hitting $39.39. The stock had a trading volume of 21,334 shares, compared to its average volume of 1,256,065. The firm has a market capitalization of $1.02 billion, a P/E ratio of 103.21, a P/E/G ratio of 2.09 and a beta of 0.37. PetIQ Inc has a 1-year low of $17.03 and a 1-year high of $41.89. The company has a debt-to-equity ratio of 0.56, a current ratio of 2.00 and a quick ratio of 0.90.

PetIQ (NASDAQ:PETQ) last released its quarterly earnings data on Tuesday, August 14th. The company reported $0.41 earnings per share for the quarter, beating the consensus estimate of $0.39 by $0.02. The business had revenue of $171.10 million for the quarter, compared to analyst estimates of $148.48 million. PetIQ had a positive return on equity of 11.40% and a negative net margin of 0.76%. PetIQ’s quarterly revenue was up 96.2% compared to the same quarter last year. equities research analysts expect that PetIQ Inc will post 0.76 EPS for the current fiscal year.

PETQ has been the subject of several recent analyst reports. SunTrust Banks lifted their price target on PetIQ to $40.00 and gave the company a “buy” rating in a report on Wednesday, August 15th. Jefferies Financial Group reaffirmed a “buy” rating and issued a $30.00 price objective on shares of PetIQ in a research note on Wednesday, May 16th. Zacks Investment Research raised PetIQ from a “sell” rating to a “hold” rating in a research note on Wednesday, June 6th. BidaskClub raised PetIQ from a “sell” rating to a “hold” rating in a research note on Friday, May 25th. Finally, ValuEngine raised PetIQ from a “hold” rating to a “buy” rating in a research note on Thursday, July 12th. One equities research analyst has rated the stock with a hold rating, three have issued a buy rating and one has issued a strong buy rating to the company. The company presently has an average rating of “Buy” and a consensus price target of $33.33.

Several hedge funds and other institutional investors have recently added to or reduced their stakes in the company. Wasatch Advisors Inc. lifted its stake in shares of PetIQ by 452.1% in the 2nd quarter. Wasatch Advisors Inc. now owns 1,944,321 shares of the company’s stock valued at $52,224,000 after purchasing an additional 1,592,157 shares in the last quarter. State of New Jersey Common Pension Fund D lifted its stake in shares of PetIQ by 571.4% in the 2nd quarter. State of New Jersey Common Pension Fund D now owns 940,000 shares of the company’s stock valued at $25,248,000 after purchasing an additional 800,000 shares in the last quarter. Park West Asset Management LLC lifted its stake in shares of PetIQ by 4.6% in the 1st quarter. Park West Asset Management LLC now owns 935,317 shares of the company’s stock valued at $24,879,000 after purchasing an additional 41,213 shares in the last quarter. BlackRock Inc. lifted its stake in shares of PetIQ by 5.5% in the 2nd quarter. BlackRock Inc. now owns 835,035 shares of the company’s stock valued at $22,427,000 after purchasing an additional 43,693 shares in the last quarter. Finally, Redwood Investments LLC lifted its position in PetIQ by 55.5% during the 1st quarter. Redwood Investments LLC now owns 749,611 shares of the company’s stock worth $19,940,000 after acquiring an additional 267,430 shares in the last quarter. 77.30% of the stock is currently owned by institutional investors and hedge funds.

About PetIQ

PetIQ, Inc develops, manufactures, and distributes pet medications, and health and wellness products for dogs and cats in the United States, Canada, and Europe. It offers pet prescription medications, including products for arthritis, thyroid, and diabetes and pain treatments, as well as heartworm preventatives, antibiotics, and other specialty medications; over-the-counter medications and supplies, such as flea and tick control products in various forms comprising spot on treatments, chewables, and collars; and health and wellness products consisting of specialty treats and other pet products, which include dental treats and nutritional supplements.

See Also: Diversification For Individual Investors

Insider Buying and Selling by Quarter for PetIQ (NASDAQ:PETQ)

Receive News & Ratings for PetIQ Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for PetIQ and related companies with MarketBeat.com's FREE daily email newsletter.